Programs, populations, and payments verified via SAMHSA.
- Level of care
- Outpatient · MAT · Telehealth
- Service settings
- Outpatient, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
- Therapy approaches
- Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy, Trauma-related counseling
- Age groups
- Young Adults, Adults
- Special populations
- Adolescents, Young adults, Clients with co-occurring mental and substance use disorders
- Medications used
- Acamprosate (Campral®), Disulfiram, Buprenorphine sub-dermal implant, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Lofexidine, Clonidine + 4 more
- Recovery supports
- Self-help groups, Housing services, Assistance with obtaining social services
- Facility operation
- Private non-profit organization